BCL9

(redirected from LGS)
Also found in: Dictionary, Acronyms, Encyclopedia, Wikipedia.

BCL9

A gene on chromosome 1q21 that encodes a phosphoprotein involved in signal transduction through the Wnt pathway, and which promotes beta-catenin's transcriptional activity.
References in periodicals archive ?
According to Tharchen, most of the corruption happens in LGs because people and the LG elected members are not aware of their mandate, obligation and roles.
LGS Innovations is helping NASA adopt laser communications for other missions with technologies such as the first deep-space laser transmitter for the Deep Space Optical Communications project, and a free-space laser modem that will fly aboard the International Space Station as the first demonstration of a fully operational, end-to-end optical communications system.
Yet, the problems pale in comparison to Punjab and Sindh, where LGs have arguably been structured to fail or certainly remain wholly dependent on the provincial set-ups.
"Amna have made modifications to LGS building technology to meet the requirements of the environmental and business conditions in GCC environment," adds Mr Mezal.
LGS will provide model simulations, design and analysis as well as scaled development and demonstration for the technology over that period.
The Axios acquisition is LGS' first since it was purchased from Alcatel-Lucent by Madison Dearborn Partners and CoVant in 2014.
LGS can also be controlled by industrial controllers, inspection systems, manufacturing execution systems (MES), and other automation.
FDA for the adjunctive treatment of seizures associated with LGS in children four years and older and in adults, and is currently marketed in the U.S.
Gibson, MSSW, DHL, ACSW, Director of Epilepsy Information Service and Associate Professor in the Department of Neurology at Wake Forest University School of Medicine, explains the impact of LGS on family members of patients, and in particular, the parents.
Under the terms of the task order, LGS will engineer, furnish, install, secure, test, and migrate a robust fiber overhaul to the base's network architecture.
Concurrently, the company proposes to start a clinical development programme for Epidiolex in the treatment of Lennox-Gastaut syndrome (LGS).
LGS Innovations, independent subsidiary of Alcatel-Lucent has been selected for a multiple-award blanket purchase agreement (BPA) by the U.S.